Full Schedule - Session development is in progress. Additional sessions and details to be added, so keep an eye on this page for more information!

8:30 AM – 9:45 AM PT

(K1) Specialty Pharmaceuticals in Development

Location: 121

Faculty: – Prime Therapeutics

Keynote

10:15 AM – 11:15 AM PT

(L4) State Legislative and Regulatory Update

Location: 112

Faculty: – AMCP

Legislative and Regulatory Trends

10:15 AM – 11:45 AM PT

(E4) WIN-WIN: Negotiate Your Career with Confidence

Location: 120

Faculty: – Purposeful Hire

The Managed Care Executive

10:15 AM – 11:30 AM PT

(W4) Advancing Patient Care and Demonstrating Value in Specialty Pharmacy Using Technology and Data-Driven Quality Improvement Solutions

Location: 123

Faculty: – Vanderbilt University Medical Center

Faculty: – Vanderbilt Specialty Pharmacy

Making the Way for Innovation

10:15 AM – 11:30 AM PT

(D4) Maximizing Utilization and Continuity of Care: Advancing Adalimumab Biosimilar Adoption in Managed Care

Location: 114

Faculty: – Devoted Health

Faculty: – Sutter Health

Drugs, Diseases, and the Managed Care Impact

2:30 PM – 3:45 PM PT

(R5) Bridging the Gap: Development of Real-World Evidence (RWE) Standards to Facilitate Communication Between Manufacturers and Payers through the AMCP RWE Initiative

Location: 123

Faculty:

Faculty: – AMCP

Faculty: – Select Health/Scripius

Faculty: – IQVIA

Managed Care Research in Action

2:30 PM – 3:45 PM PT

(M5) Current Patterns, Future Shifts, and Best Practices in U.S. Specialty Drug Coverage

Location: 114

Faculty: – University of Utah

Faculty: – Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center

Faculty: – Optum

Focus on Managed Care Pharmacy

2:30 PM – 3:45 PM PT

(SP2) Pharmacoeconomics & Formulary Management Student Workshop

Location: 120

Faculty: – Lumanity

Faculty: – Blue Cross Blue Shield of Michigan

2:30 PM – 3:45 PM PT

(D5) Advancing Schizophrenia Management Strategies in the Patient Journey: Treatment Innovations, Adherence, and Health Outcomes

Location: 121

Faculty: – University of Maryland School of Pharmacy

Faculty: – University of Maryland, School of Pharmacy

Faculty: – The CURESZ Foundation

Drugs, Diseases, and the Managed Care Impact

4:15 PM – 5:30 PM PT

(L6) CY 2025 Part D Redesign: A Medicare Odyssey

Location: 123

Faculty: – BluePeak Advisors

Legislative and Regulatory Trends

4:15 PM – 5:30 PM PT

(E6) Exploring the Future: What’s Next for Managed Care Pharmacists Approaching Retirement

Location: 120

Faculty: – University of Utah

Faculty: – Associate Professor, Family Medicine and Community Health / UMass Chan Medical School

Faculty: – Prime Therapeutics

Faculty: – Retired

Moderator: – Prime Therapeutics

The Managed Care Executive

4:15 PM – 5:30 PM PT

(R6) GLP-1 Agonists for Weight Management within the Commercially Insured Market: How Real-world Evidence Can Inform Benefit Design

Location: 121

Faculty: – Prime Therapeutics

Faculty: – Lockton

Faculty: – Prime Therapeutics, LLC

Managed Care Research in Action